Category: Biologics
Global Biologics
-
Healthcare Distribution Market - By Type (Pharmaceutical [OTC, Generic, Branded Drugs], Biopharmaceutical [Vaccines, Monoclonal Antibodies], & Medical Device Distribution Services), End-use (Hospital, Retail Pharmacies) – Global Forecast (2024 – 2032)
... demonstrate a 7.1% CAGR between 2024 and 2032, propelled by innovations in warehouse management systems (WMS) and a heightened focus on patient safety. Advanced WMS technologies improve efficiency, accuracy, and regulatory compliance, ensuring the secure ... Read More
-
Biopharmaceutical CMO and CRO Market Share, Global Industry Growth, Analysis, Size and Forecast 2024-2032
... 2024 to 2032. The biopharmaceutical industry has witnessed tremendous growth in recent years, fueled by advancements in biotechnology, the increasing prevalence of chronic diseases, and a heightened focus on personalized medicine. Central to this growth ... Read More
-
Fill-Finish Manufacturing Market Report 2024-2034
... underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Fill-Finish Manufacturing is Held to the Very Highest Regulatory ... Read More
-
Blockchain in Healthcare Market Share, Size, Trends, Industry Analysis Report, By End-Use (Healthcare Payers, Biopharmaceutical & Medical Device Companies, Healthcare Providers); By Network Type; By Application; By Region; Segment Forecast, 2024 - 2032
... blockchain in healthcare market size is expected to reach USD 105698.76 million by 2032, according to a new study by Polaris Market Research. The report “Blockchain in Healthcare Market Share, Size, Trends, Industry Analysis Report, ... Read More
-
Biosimilars and Follow-On Biologics Market Report 2024-2034
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increasing Demand of Drugs For Treating ... Read More
-
Global Atopic Dermatitis Drugs Market 2024-2028
... period. Our report on the atopic dermatitis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (captive, merchant), Synthesis (Synthetic, Biotech), Products (mAb, Hormones, Cytokines), Drug (OTC, Rx), Application (Diabetes, oncology, CVD) - Global Forecast to 2029
... market is projected to reach USD 238.3 billion by 2029 from USD 163.5 billion in 2024, at a CAGR of 7.8% during the forecast period of 2024 to 2029. The growth of this market can ... Read More
-
Protein A Resin Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... reach USD 1.78 billion by 2029, growing at a CAGR of 8.69% during the forecast period (2024-2029). According to Cancer Facts and Figures 2023 by the American Cancer Society, the number of new cancer cases ... Read More
-
Prefilled Syringes: Global Markets
... of compound annual growth rates (CAGRs) through 2029 (forecast period 2024 to 2029) and regional markets for prefilled syringes. This report will highlight prefilled syringes’ current and future market potential and a detailed competitive environment ... Read More
-
Single-use Assemblies Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... impact of COVID-19 on the single-use assemblies market as there was growing adoption of single-use technology for research activities in COVID-19 vaccine development. Many players focused on R&D activities to develop a vaccine requiring single-use ... Read More
-
Biopharmaceutical Process Analytical Technology Market Size by Technology (LC, GC, MS, qPCR, NGS, NMR, Raman, IR Spectroscopy), Product (Analyzer, Sensor, Software), Application (Vaccine, Biologics, CGT), and End User - Global Forecast to 2029
... biopharmaceutical process analytical technology market is projected to reach USD 2.6 billion by 2029 from USD 1.2 billion in 2024, at a CAGR of 16.0% during the forecast period of 2024 to 2029. The market ... Read More
-
Biopharmaceutical Contract Manufacturing Organization (CMO) Global Market Opportunities And Strategies To 2033
... And PackagingCovering: Catalent Inc.; Cytiva; Rentschler Biopharma; Boehringer Ingelheim GmbH; AGC Biologics Inc. Biopharmaceutical Contract Manufacturing Organization (CMO) Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and ... Read More
-
Biologics Safety Testing Market by Product & Service (Consumables, Instrument, Services), Test Type (Mycoplasma, Sterility, Endotoxin, Bioburden, Virus Safety), Application (Vaccines, mAbs, Cell & Gene Therapy, Blood Products) - Global Forecast to 2029
... safety testing market is projected to reach USD 7.2 billion by 2029 from an estimated USD 4.2 billion in 2024, at a CAGR of 11.1% from 2024 to 2029. The growth of this market can ... Read More
-
Global Autoimmune Disease Treatment Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the Autoimmune Disease Treatment industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Autoimmune Disease Treatment. The report also introduces players ... Read More
-
Microcarrier Market Analysis and Forecast to 2033: By Material Type (Collagen-based, Gelatin-based, Hyaluronic Acid-based, Polystyrene-based, Dextran-based, Modified Polyvinyl Alcohol), Technology (Two-Dimensional, Three-Dimensional), Application (Regenerative Medicine, Cultured Meat Production, Vaccine Production, Cell Therapy, Biologics Manufacturing, Stem Cell Research, Tissue Engineering), Equipment (Bioreactors, Cell Culture Vessels, Centrifuges, Incubators, Cell Counters, Separation Systems, Storage Systems, Processing Systems), Size of Microcarriers [Small (<1,000 µm), Medium (1,000–2,000 µm), Large (>2,000 µm)], End-User (Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institutes), and Region
... Cell Research, Tissue Engineering), Equipment (Bioreactors, Cell Culture Vessels, Centrifuges, Incubators, Cell Counters, Separation Systems, Storage Systems, Processing Systems), Size of Microcarriers [Small ( 2,000 µm)], End-User (Biopharmaceutical Companies, Contract Research Organizations, Academic and Research ... Read More
-
Rare Disease Treatment Market – By Drug Type (Biologics, Non-biologics), Therapeutic Area (Cancer, Respiratory Disorder, Cardiovascular Disorder), Patient (Adult, Pediatric), Route of Administration (Oral, Injectable) – Global Forecast (2024 2032)
... Market will reach a 9% CAGR from 2024 to 2032, attributed to advancements in medical research coupled with robust biopharmaceutical investments. Breakthroughs in gene therapies, precision medicine, and targeted treatments are reshaping therapeutic approaches. Moreover, ... Read More
-
2024 Global Forecast for Protein A Resin Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
2024 Global Forecast for Biologics Contract Development Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD ... Read More
-
2024 Global Forecast for Compound Management Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD xx ... Read More
-
Global Biologics and Biosimilars Market Size, Manufacturers, Opportunities and Forecast to 2030
... biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. ... Read More
-
Global Biologics and Biosimilars Market Analysis and Forecast 2024-2030
... proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. A biosimilar in ... Read More
-
Global Biologics and Biosimilars Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but ... Read More
-
Global Biologics and Biosimilars Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a ... Read More
-
Global Wound Care Biologics Databank Market Report
... 2023 to 2031. Ulcers segment is expected to be the highest contributor to this market, with $730.2 Million in 2022, and is anticipated to reach $1,212.3 Million by 2031, registering a CAGR of 5.84%. Surgical ... Read More
-
Biologics CDMO Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... billion by 2029, growing at a CAGR of 12.78% during the forecast period (2024-2029). With an increasing number of companies within the pharmaceutical sector considering outsourcing services, the demand for services from contract manufacturing and ... Read More
Research Assistance
